Symbol="TRVN"
AssetType="Common Stock"
Name="Trevena Inc"
Description="Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of new drugs for patients affected by disorders of the central nervous system. The company is headquartered in Chesterbrook, Pennsylvania."
CIK="1429560"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="10420600"
EBITDA="-49689000"
PERatio="None"
PEGRatio="0"
BookValue="1.131"
DividendPerShare="0"
DividendYield="0"
EPS="-6.48"
RevenuePerShareTTM="-0.055"
ProfitMargin="0"
OperatingMarginTTM="115.85"
ReturnOnAssetsTTM="-0.609"
ReturnOnEquityTTM="-1.515"
RevenueTTM="-432000"
GrossProfitTTM="-3436000"
DilutedEPSTTM="-6.48"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.7"
AnalystTargetPrice="20"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="106.03"
PriceToBookRatio="0.569"
EVToRevenue="18.8"
EVToEBITDA="0.132"
Beta="1.902"
num_52WeekHigh="8.5"
num_52WeekLow="0.58"
num_50DayMovingAverage="1.067"
num_200DayMovingAverage="1.922"
SharesOutstanding="10969000"
DividendDate="None"
ExDividendDate="None"
symbol="TRVN"
open="0.93"
high="0.94"
low="0.91"
price="0.92"
volume="131254.00"
latest_trading_day="2023-07-14"
previous_close="0.93"
change="-0.00"
change_percent="-0.1081%"
aroon_positive_momentum_days="47"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="47"
Volume_recent_avg="1834501"
Change_recent_avg="-0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.88"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="47"
Aroon_momentum_negative="53"
image_negative_thumbnail_id_1="1116"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0149.jpeg"
image_negative_thumbnail_id_2="1120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="617"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0091.jpeg"
image_positive_thumbnail_id_2="992"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0154.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
